Pendulum Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 78
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $55M
Latest Deal Amount
  • Investors
  • 15

Pendulum Therapeutics General Information

Description

Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackle type 2 diabetes. The company integrates laboratory science and computational analysis to gain a comprehensive view of each individual's microbiome through targeted probiotics and prebiotics and has developed drugs for the dietary management of type 2 diabetes, thus enabling clinicians to identify specific microbiome markers and interventions to treat diseases.

Contact Information

Website
www.pendulumlife.com
Formerly Known As
Whole Biome
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Other Healthcare Technology Systems
Primary Office
  • 933 20th Street
  • San Francisco, CA 94107
  • United States
+1 (844) 000-0000

Pendulum Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pendulum Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 01-Apr-2021 $55M 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series B) 30-May-2019 0000 000.00 00000 Completed Generating Revenue
7. Early Stage VC (Series A2) 08-Jun-2017 000.00 000.00 000.00 Completed Generating Revenue
6. Early Stage VC (Series A) 26-Jan-2016 000 0000 0000 Completed Startup
5. Grant 01-Jan-2016 00000 000 Completed Startup
4. Seed Round 15-Dec-2014 000 000 000.00 Completed Startup
3. Accelerator/Incubator 18-Jun-2014 Completed Startup
2. Accelerator/Incubator 13-Oct-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Pendulum Therapeutics’s complete valuation and funding history, request access »

Pendulum Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 11,797,144 $0.000100 $0.05 $0.68 $0.68 1x $0.68 12.97%
Seed 5,785,203 $0.000100 $0.05 $0.64 $0.64 1x $0.64 6.36%
To view Pendulum Therapeutics’s complete cap table history, request access »

Pendulum Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackle
Drug Discovery
San Francisco, CA
78 As of 2021
00000
0000 0000-00-00
00000000000 00000

0000 000

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit ess
0000 000000000
Somerville, MA
0 As of 0000
00.00
00000000000 00.00

00000000

mmodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fug
00000 0000000000 0000000000 0000000
Research Triangle Park, NC
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pendulum Therapeutics Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xeno Biosciences Venture Capital-Backed Somerville, MA 0 00.00 00000000000 00.00
000000000 Venture Capital-Backed Research Triangle Park, NC 000 00000 00000000000 00000
00000000 Formerly VC-backed Roseville, MN 00 000.00 000000&0 000.00
00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000000 00000
0000000 000000000 Venture Capital-Backed Madison, WI 00 000.00 000000000 - 000.00
You’re viewing 5 of 22 competitors. Get the full list »

Pendulum Therapeutics Patents

  • 58

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

Pendulum Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3137104-A1 Microbial compositions and methods for greater tolerability and prolonged shelf life Pending 22-Apr-2019 0000000000
AU-2020261345-A1 Microbial compositions and methods for greater tolerability and prolonged shelf life Pending 22-Apr-2019 0000000000
US-20210213078-A1 Microbial compositions and methods of use Pending 24-Sep-2018 0000000000
CA-3113684-A1 Microbial compositions and methods of use Pending 24-Sep-2018 0000000000
EP-3856214-A1 Microbial compositions and methods of use Pending 24-Sep-2018 A61K31/155
To view Pendulum Therapeutics’s complete patent history, request access »

Pendulum Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Colleen Cutcliffe Ph.D Co-Founder, Chief Executive Officer & Board Member
James Bullard Ph.D Co-Founder & Chief Technology Officer
John Eid Ph.D Co-Founder, Chief Scientific Officer & Board Member
Matthew Murphy JD General Counsel
Orville Kolterman MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Pendulum Therapeutics Board Members (9)

Name Representing Role Since
Adam D'Augelli True Ventures Board Member 000 0000
Colleen Cutcliffe Ph.D Pendulum Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Craig Sherman Meritech Capital Partners Board Member 000 0000
Heather Mason Pendulum Therapeutics Board Member 000 0000
Hugh Martin Self Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Pendulum Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pendulum Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Meritech Capital Partners Venture Capital Minority 000 0000 000000 0
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
SK Ventures Venture Capital Minority 000 0000 000000 0
Felicis Ventures Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial